Piper Sandler analyst David Westenberg raised the firm’s price target on Natera to $110 from $70 and keeps an Overweight rating on the shares. The firm cites the company’s earnings results.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NTRA:
- New Share Price & Shareholder Rights Risk for Natera Inc. – What’s the Latest?
- CMS announcement positive for CareDx and Natera, says Craig-Hallum
- CMS says transplant patients can continue to access blood tests
- Natera price target raised to $110 from $87 at TD Cowen
- Natera price target raised to $100 from $87 at Canaccord
